A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection
Controlled trials have shown that treatment with zidovudine (Retrovir) late in the course of infection with the human immunodeficiency virus (HIV) type 1 results in decreased rates of disease progression and death, 1 , 2 but there is no consensus on the benefit of antiretroviral treatment in asympto...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 1995-08, Vol.333 (7), p.408-413 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!